2013; 52(1): 69-80 Eminaga O, Hinkelammert R, Abbas M , Titze U, Eltze E, Bettendorf O, Semjonow A: High-grade prostatic intraepithelial neoplasia (HGPIN) and topographical distribution in 1,374 prostatectomy [...] --an underdiagnosed entity in younger adults with lobar intracerebral hemorrhage? Amyloid ; 20(1): 45-47 Rafikova O, Rafikov R, Kumar S, Sharma S, Aggarwal S, Schneider F, Jonigk D , Black SM, Tofovic [...] er P, Collins VP, Pfister SM, von Deimling A: AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry. Acta Neuropathol 2013; 126(5):

and citrullination in the LEW.1AR1-iddm rat, an animal model of human type 1 diabetes, and effects of anti-TCR/anti-TNF-α antibody-based therapy. Amino Acids. 2020 Jan;52(1):103-110. doi: 10.1007/s0072 [...] Invest . 129(1), 422-436. Arndt T , Jörns A, Wedekind D (2018) Changes in immune cell frequencies in primary and secondary lymphatic organs of LEW.1AR1-iddm rats, a model of human type 1 diabetes compared [...] lysine and effects of anti-TCR/anti-TNF-α antibody-based therapy in the LEW.1AR1- iddm rat, an animal model of human type 1 diabetes. Int J Mol Sci. 2022 Jan 28;23(3):1541. doi: 10.3390/ijms23031541. PMID:

for growth factors on serious adverse events (OR 1.09, 95% CI 0.79 to 1.50; 13 studies, N = 1411) and on any adverse events (OR 1.10, 95% CI 0.73 to 1.64; 4 studies, N = 709) at up to two years are also [...] for growth factors on major limb amputations (OR 0.99, 95% CI 0.71 to 1.38; 10 studies, N = 1075) and death (OR 0.99, 95% CI 0.69 to 1.41; 12 studies, N = 1371) at up to two years are uncertain. The quality [...] Band 133; 1. Auflage, Köln 2015. Hagen A , Gorenoi V, Schönermark MP. Knochenersatzmaterialien zur Behandlung von traumatischen Frakturen der Extremitäten. Schriftenreihe HTA des DIMDI, Band 119; 1. Aufl.

Rothgang H, Klawunn R, Walzer S, & Kley T. Wiesbaden: Springer Fachmedien Wiesbaden. S. 1–16. DOI: 10.1007/978-3-658-39302-1_1 Krückeberg J, Beume D, Klawunn R , & Hechtel N (2023). Einführungsprozesse technischer [...] between onset of symptoms and diagnostic delay in women with endometriosis. Arch Clin Obs Gyn Res. 2020;1(1):1-7. Chassagnol F, Marcelli G, Wagle J, Giuliani G, Traub D, Schaub V, Ruof J (2020). Review of Relative [...] org). Volume 11, Issue 1. Klawunn R , Katzmarzyk D , Dierks M-L , Albrecht U-V (2026). Resonanz in der digitalen Transformation pflegerischer Versorgung. Public Health Forum 2026; 34(1): 68–73 Kraft L , Brecher

Cardiovasc Surg 2009; no. 1:1-5. Shrestha M, Baraki H, Khaladj N, Koigeldiyev N, Haverich A, Hagl C: Do Patients Profit from Third Time CABG? Open J Cardiovasc Surg 2009; no. 2:1-5. Tudorache I, Kostin S [...] Targeting Endothelial Cells with Multifunctional GaN/Fe Nanoparticles. Nanoscale Res Lett 12, no. 1:486. Granados, M.*, Morticelli, L.*, Andriopoulou, S., Kalozoumis, P., Pflaum, M., Iablonskii, P., [...] 30:177. Ramm, R., Niemann, H., Petersen, B., Haverich, A., and Hilfiker, A. 2016. Decellularized GGTA1-KO pig heart valves do not bind preformed human xenoantibodies. Basic Res Cardiol 111, no. 4:39. Theodoridis

older adults in Germany. International Journal for Equity in Health. 2024;23(1):138. https://doi.org/10.1186/s12939-024-02224-1 Tetzlaff J, Epping J, Stahmeyer JT, Liebers F, Hegewald J , Sperlich S, Beller [...] myocardial infarction and after incidence. Population Health Metrics, 2021, 19:47. https://doi.org/10.1186/s12963-021-00280-1 Safieddine B, Sperlich S, Epping J, Lange K, Geyer S (2021). Development of [...] type 2 diabetes in Lower Saxony, Germany. Journal of Public Health. 2017;25(1):19-28. https://doi.org/10.1007/s10389-016-0756-1 Tetzlaff J, Junius-Walker U, Muschik D, Epping J, Eberhard S, Geyer S . Identifying

Stokkeland K, Ericzon BG, Jonigk D , Janciauskiene S, Nowak G, Ellis ECS: Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression. PLoS One 2017; 12(5): e0177279 Keller G, Steinmann D, Quaas A, Grünwald [...] IE: Brain arteriovenous malformations: implications of CEACAM1-positive inflammatory cells and sex on hemorrhage. Neurosurg Rev 2017; 40(1): 129-134 Neyazi B, Tanrikulu L, Wilkens L, Hartmann C , Stein [...] Ueffing M, Gossler A: 1700012B09Rik, a FOXJ1 effector gene active in ciliated tissues of the mouse but not essential for motile ciliogenesis. Dev Biol 2017; 429(1): 186-199 Taubert R, Hardtke-Wolenski M,

Wahrnehmung und Herstellung von Geschlecht. Perceiving and Performing Gender. Opladen, Wiesbaden, 1999, S. 47-62 „Diskurse und Erfahrungen. Ein Rückblick auf die Körpergeschichte der 90er Jahre”, in: 1999. Zeitschrift [...] 1960er Jahre“, in: NTM. Zeitschrift für Geschichte der Wissenschaft, Technik und Medizin 17 (2009) 1, S. 55-83 „Der aktuelle Gebrauch der longue durée in der Wissenschaftsgeschichte“, in: Berichte zur [...] Kurorte in der Region. Gesellschaftliche Praxis, kulturelle Repräsentationen und Gesundheitskonzepte vom 1. bis zum 21. Jahrhundert. Göttingen: Wallstein 2024, S. 33-46 "Sittlichkeit und sexuelle Freiheit. Zur

d Virus 2 (AAV2) Rep in Coinfections with Herpes Simplex Virus 1 (HSV-1) Gives Rise to a Mosaic of Cells Replicating either AAV2 or HSV-1. Franzoso FD, Seyffert M, Vogel R, Yakimovich A, de Andrade Pereira [...] Gerhard Winter, Stylianos Michalakis J Pharm Sci. 2020 Jan;109(1):854-862.doi: 10.1016/j.xphs.2019.10.031. Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice Richard [...] Odenthal, Sahil Adriouch, Anna Salvetti, Hildegard Büning Sci Rep. 2019 Mar 6;9(1):3631.doi: 10.1038/s41598-019-40071-1. Enhancing Lentiviral and Alpharetroviral Transduction of Human Hematopoietic Stem

in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial. Clin Cancer Res . 32:214-223 Christgen M*, Bartels S, Kreipe H (2025). NMD-insensitive CDH1 mutation as a mechanism for retained E-cadherin protein [...] breast cancer (BC9-a translational analysis of the prospective WSG PlanB trial. Breast Cancer Res 22(1):47. Schaumann N, Raap M, Hinze L, Rieger L, Schurch CM, Antonopoulos W, Avril S, Krech T, Dammrich M [...] Reddy S, Christgen M, and Zippelius A (2015). Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade. Sci Transl Med 7:315ra188. Christgen M, Winkens W, and Kreipe